UK Consultation on e-cigarette advertising

September 15th, 2017 by

The  UK’s CAP (Committee of Advertising Practice) and BCAP (Broadcast Committee of Advertising Practice) have today launched a consultation on proposed changes to each of their codes, which would remove the prohibition on making health claims for electronic cigarettes. If approved it will mean that such claims, where they can be substantiated and are not […]

New study shows no evidence that e-cigarettes lead young people into smoking

August 30th, 2017 by

A collaboration between the UK Centre for Tobacco and Alcohol Studies, Public Health England (PHE), Action on Smoking and Health (ASH), and the DECIPHer Centre at the University of Cardiff, studied data from five surveys involving over 60,000 11-16 year-olds – the largest ever analysis of data in the UK. The data showed no evidence that e-cigarettes […]

US regulatory deadline extended

August 15th, 2017 by

The changing face of regulation In recent years, there has been significant international growth for products that deliver nicotine without the requirement to burn tobacco. As a result, there has also been a significant and varied increase in regulation, leading to a marked difference between the way nicotine and tobacco-containing products are regulated and perceived […]

How Square is a Square Wave?

August 8th, 2017 by

At this summer’s Global Forum on Nicotine (GFN) in Warsaw, Nerudia Lead Scientist Paul Hardman presented in the scientific poster session. The poster, ‘How Square is a Square Wave?’, compares methods for capturing aerosol from electronic cigarettes, in order to test the emissions. The study was carried out by Rhys Wadkin, Regulatory Scientist. Rhys explains: […]

PMTA Bridging Strategy

July 27th, 2017 by

Any company that’s been looking at the amount of product testing required by the Food and Drug Administration (FDA) for Premarket Tobacco Applications (PMTA) will understand just how extensive and expensive this can be. At Nerudia, we have used our extensive experience in the vaping and pharmaceutical industries to develop a Bridging Strategy aimed at […]